Hybrid 2024

Health Bioscience Research Industry Days, Paris, France

HYBRID is the convergence of a scientific congress, where the latest advances are presented by their authors, and B2B meeting sessions. For this edition, 50 academic teams selected by Inserm including Pr. Annarita Miccio’s lab, 20 startups selected by Bpifrance, France Biotech, and Inserm Transfert, as well as international R&D teams from health industry, mobilized to make Hybrid2024 a success.